Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10103339rdf:typepubmed:Citationlld:pubmed
pubmed-article:10103339lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0871489lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0021270lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0599685lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0663655lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C0540137lld:lifeskim
pubmed-article:10103339lifeskim:mentionsumls-concept:C1318970lld:lifeskim
pubmed-article:10103339pubmed:issue4lld:pubmed
pubmed-article:10103339pubmed:dateCreated1999-4-15lld:pubmed
pubmed-article:10103339pubmed:abstractTextTo evaluate the pharmacokinetic features, safety, and tolerance of abacavir, given alone and in combination with other nucleoside antiretroviral agents, in symptomatic human immunodeficiency virus (HIV)-infected children.lld:pubmed
pubmed-article:10103339pubmed:languageenglld:pubmed
pubmed-article:10103339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10103339pubmed:citationSubsetIMlld:pubmed
pubmed-article:10103339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10103339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10103339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10103339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10103339pubmed:statusMEDLINElld:pubmed
pubmed-article:10103339pubmed:monthAprlld:pubmed
pubmed-article:10103339pubmed:issn1098-4275lld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:BlanchardSSlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:FletcherC VCVlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:KovacsAAlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:DanknerW MWMlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:McDowellJ AJAlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:McKinneyR...lld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:KlineM WMWlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:BrundageR CRClld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:Van DykeR BRBlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:ShenepJ LJLlld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:HetheringtonS...lld:pubmed
pubmed-article:10103339pubmed:authorpubmed-author:CulnaneMMlld:pubmed
pubmed-article:10103339pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10103339pubmed:volume103lld:pubmed
pubmed-article:10103339pubmed:ownerNLMlld:pubmed
pubmed-article:10103339pubmed:authorsCompleteYlld:pubmed
pubmed-article:10103339pubmed:paginatione47lld:pubmed
pubmed-article:10103339pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:meshHeadingpubmed-meshheading:10103339...lld:pubmed
pubmed-article:10103339pubmed:year1999lld:pubmed
pubmed-article:10103339pubmed:articleTitleA phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.lld:pubmed
pubmed-article:10103339pubmed:affiliationDepartment of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas 77030, USA.lld:pubmed
pubmed-article:10103339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10103339pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10103339pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10103339pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10103339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10103339pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10103339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10103339lld:pubmed